Skip to main content
. 2016 Nov 1;115(12):1495–1503. doi: 10.1038/bjc.2016.352

Table 2. Characteristics of respondents to the DCE.

  n(%)
Gender (n=668)
Male 302 (45.2)
Female 366 (54.8)
Cancer site (n=668)
Breast 213 (31.9)
Colorectal 165 (24.7)
Prostate 158 (23.6)
Melanoma 132 (19.8)
Age (years) (n=667)
Under 40 20 (3.0)
41–50 76 (11.4)
51–60 147 (22.0)
61–70 219 (32.8)
71–80 175 (26.3)
Over 81 30 (4.5)
Time since diagnosis (years) (n=667)
<1 year 7 (1.1)
1–2 years 112 (16.8)
2–5 years 367 (55.0)
Over 5 years 181 (27.1)
Recurrence (n=658)
Yes 80 (12.2)
No 578 (87.8)
Currently attending cancer follow-up clinic (n=663)
Yes 529 (79.8)
No 134 (20.2)
Healthcare provider seen for follow-upa
Consultant 604 (58.3)
Registrar/Trainee doctor 140 (13.5)
Specialist nurse 175 (16.9)
Specialist GP 21 (2.0)
Own GP 69 (6.7)
Other 22 (2.1)
Cannot say 5 (0.5)
Travelling time to attend follow-up (n=553)
Up to 15 min 83 (15.0)
Between 15–30 min 178 (32.2)
Between 31–60 196 (35.4)
61 min or more 95 (17.2)
Cannot say 1 (0.2)
Cohabitation status, currently living with (n=665)
Spouse/partner 454 (68.3)
Family 100 (15.0)
Alone 111 (16.7)

Abbreviations: GP=general practitioner.

a

Some respondents selected more than one healthcare provider.